Dementia is not a single disease. It’s an umbrella term for a decline in memory, thinking, and reasoning severe enough to interfere with daily life, and it has many distinct causes. Over 55 million people worldwide live with dementia, with roughly 10 million new cases diagnosed each year. The specific cause matters because it determines how the condition progresses, what symptoms appear first, and whether treatment can slow or even reverse the decline.
Alzheimer’s Disease
Alzheimer’s accounts for 60 to 80 percent of all dementia cases, making it by far the most common cause. Two abnormal proteins drive the damage: amyloid plaques that build up between brain cells and tau tangles that form inside them.
Amyloid plaques were once considered the primary villain, but the picture is more complicated. Plaques actually accumulate with age even in healthy brains, and the number of plaques often doesn’t correlate with how much cognitive decline a person experiences. Researchers now believe that smaller, soluble forms of amyloid are the real toxic drivers, particularly in early disease. These soluble fragments disrupt the connections between brain cells long before large plaques become visible on a scan. The plaques themselves may actually serve as a kind of storage depot for these toxic fragments, containing them until they reach a saturation point.
Tau tangles cause a different type of destruction. Tau normally helps stabilize the internal scaffolding that neurons rely on to transport nutrients and signals. When tau misfolds and clumps together, that scaffolding collapses, cutting off the cell’s supply lines and eventually killing it. The two proteins also amplify each other: amyloid buildup accelerates the spread of tau tangles into new brain regions, and their combined presence causes more neuronal loss than either one alone. This synergy helps explain why Alzheimer’s is progressive and why damage tends to spread from memory areas outward to regions controlling language, spatial awareness, and eventually basic body functions.
Vascular Dementia
Vascular dementia is the second most common type, caused by reduced blood flow to the brain. When brain cells don’t get the oxygen and nutrients they need, they die. This can happen suddenly after a stroke, when a blood clot blocks an artery or a blood vessel bursts and causes bleeding. It can also happen gradually through small vessel disease, where the tiny blood vessels deep inside the brain narrow and harden over time, slowly starving the surrounding tissue.
The risk factors for vascular dementia overlap heavily with those for heart disease: high blood pressure, high cholesterol (particularly high LDL), diabetes, and smoking all damage blood vessels throughout the body, including the brain. Atherosclerosis, the buildup of fatty deposits inside artery walls, directly reduces blood flow to the brain and is a major contributor. Unlike Alzheimer’s, where decline tends to be slow and steady, vascular dementia sometimes progresses in noticeable “steps,” with sudden drops in function following new vascular events, though the gradual small vessel form can look very similar to Alzheimer’s from the outside.
Lewy Body Dementia
Lewy body dementia involves clumps of a protein called alpha-synuclein that form inside brain cells. These clumps, called Lewy bodies, are toxic to neurons and are the same protein deposits found in Parkinson’s disease. The key difference is where in the brain the damage starts. In Parkinson’s, Lewy bodies first appear in the brainstem, which controls movement. When they spread outward into the cerebral cortex, the thinking and perception regions, dementia follows. In Lewy body dementia, cortical involvement happens earlier, so cognitive symptoms appear alongside or even before movement problems.
The hallmark features of Lewy body dementia set it apart from other types. Visual hallucinations (often vivid and detailed) are common. Attention and alertness fluctuate dramatically, sometimes within the same day. Sleep disturbances, particularly acting out dreams during sleep, frequently appear years before other symptoms. Research using alpha-synuclein antibodies to detect Lewy bodies in brain tissue has shown that cortical Lewy bodies are 91 percent sensitive and 90 percent specific as markers for dementia in Parkinson’s disease, confirming that the spread of this protein into the cortex is the primary driver, rather than co-existing Alzheimer’s pathology as was previously assumed.
Frontotemporal Dementia
Frontotemporal dementia (FTD) targets the frontal and temporal lobes of the brain, the areas responsible for personality, behavior, and language. It tends to strike earlier than other forms of dementia, often between ages 45 and 65, and its initial symptoms are frequently mistaken for psychiatric conditions rather than neurodegeneration.
The underlying protein abnormalities in FTD fall into two main categories. In some cases, tau protein accumulates abnormally, similar to Alzheimer’s but in different brain regions. In others, a protein called TDP-43, which normally lives in the cell nucleus and helps manage genetic instructions, misfolds and accumulates in the body of the cell where it doesn’t belong. These TDP-43 deposits are also found in amyotrophic lateral sclerosis (ALS), and the two conditions can overlap in the same person. FTD has a stronger genetic component than most other dementias. Mutations in several genes can cause familial forms, and roughly a third of people with FTD have a significant family history of the disease.
Mixed Dementia
Many people, especially those over 90, don’t have just one type of dementia pathology. They have several. Research from the National Institute on Aging found that mixed pathologies were present in 45 percent of people with dementia, compared to only 14 percent of those without symptoms. The more types of pathology present in the brain, the worse the cognitive decline: dementia prevalence climbed from 22 percent in people with no identifiable pathology to 95 percent in those with three or more.
A common combination is Alzheimer’s pathology alongside vascular damage and a condition called hippocampal sclerosis, where cells in the brain’s memory center shrink and scar. People with these mixed pathologies had more severe symptoms than those with Alzheimer’s changes alone. This finding has shifted how researchers think about dementia in older adults. Rather than a single disease process, late-life dementia is often the cumulative result of multiple insults to the brain compounding each other.
Rare and Rapidly Progressive Causes
Creutzfeldt-Jakob disease (CJD) is the most well-known rapidly progressive dementia, caused by prions, infectious proteins that trigger normal brain proteins to misfold in a chain reaction. CJD is always fatal, typically within a year of symptom onset, and progresses far faster than other dementias. Symptoms include rapidly worsening confusion, involuntary muscle jerks, vision problems, and eventually an inability to move or speak. It is rare, affecting roughly one to two people per million each year.
Reversible Causes That Mimic Dementia
Not all dementia-like symptoms come from irreversible brain damage, and this is one of the most important things to understand about dementia’s causes. Vitamin B12 deficiency can produce rapidly progressive cognitive decline that is fully reversible with treatment. An underactive thyroid gland slows metabolism throughout the body, including the brain, causing memory problems, mental sluggishness, and confusion that resolve once thyroid levels are corrected.
Infections can also mimic dementia. HIV encephalitis and neurosyphilis both cause progressive cognitive impairment that can be treated with appropriate antimicrobial therapy. Autoimmune conditions, where the immune system mistakenly attacks brain tissue, can present with confusion and memory loss that responds to immune-suppressing treatment. Normal pressure hydrocephalus, a buildup of fluid in the brain’s ventricles, causes a characteristic triad of walking difficulty, urinary incontinence, and cognitive decline that can improve with surgical drainage. These treatable conditions are a key reason why a thorough medical workup matters when someone develops cognitive symptoms, rather than assuming the cause is Alzheimer’s or another irreversible process.
Modifiable Risk Factors
A significant portion of dementia risk comes from factors that are, at least in theory, controllable. Hearing loss in midlife is one of the largest individual contributors. The mechanisms aren’t fully understood, but reduced auditory input may accelerate brain atrophy and increase social isolation, both of which raise dementia risk independently. High blood pressure in midlife damages blood vessels in the brain, contributing to both vascular dementia and worsening Alzheimer’s pathology. Obesity, physical inactivity, excessive alcohol use, diabetes, depression, smoking, air pollution, and low educational attainment all add measurable risk.
Social isolation and lack of cognitive engagement in later life also contribute. The brain’s ability to compensate for accumulating damage, sometimes called cognitive reserve, is partly built through years of mental stimulation, social connection, and education. Two people can have the same amount of pathology in their brains, yet the one with greater cognitive reserve may function normally while the other shows clear dementia symptoms. This helps explain why staying physically active, socially connected, and mentally engaged throughout life appears protective, even though it doesn’t prevent the underlying pathology from forming.